NEW YORK, July 2, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. ("Cibus" or the "Company") (NASDAQ: CBUS). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980. The investigation concerns whether Cibus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On June 4, 2024, Bonitas Research ...

Additional patents issued for 10 plant trait and editing families in the past two quarters. Strengthens Cibus' intellectual property portfolio in its Pod Shatter Reduction (PSR), Herbicide Tolerances (HTs), High Fiber Wheat and Improved Quality Alfalfa trait families. SAN DIEGO, June 26, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has expanded its intellectual pr ...

Additional patents issued for 10 plant trait and editing families in the past two quarters. Strengthens Cibus' intellectual property portfolio in its Pod Shatter Reduction (PSR), Herbicide Tolerances (HTs), High Fiber Wheat and Improved Quality Alfalfa trait families. SAN DIEGO, June 26, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced that it has expanded its intellectual pr ...

BOSTON, June 18, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Cibus, Inc. (Nasdaq: CBUS) for potential securities law violations. Investors who have lost money in their Cibus investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/cbus. What is this all about? Shares of Cibus fell significantly after Bonitas Research issued a report alleging that they "found no evidence that Cibus' gene-editing technology ...

Nutrient Use Efficiency Traits are an Important Large Category of Traits that can Make Fertilizer Use More Efficient on a Global Basis The First Case of Cibus Using its Trait Machine Process for a Third Party Developed Trait SAN DIEGO, June 17, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. ("Cibus" or the "Company") (NASDAQ:CBUS), a leading agricultural technology company that develops and licenses plant traits to seed companies for royalties, today announced it has confirmed it has successfully made edits in Canola ...

NEW YORK, June 13, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. (“Cibus” or the “Company”) (NASDAQ: CBUS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Cibus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On June 4, 2024, Bonitas R ...

SAN DIEGO, June 12, 2024 (GLOBE NEWSWIRE) -- Cibus, Inc. (NASDAQ:CBUS) (the "Company" or "Cibus"), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced it has entered into securities purchase agreements with institutional, strategic and existing investors of the Company, as well as with the Company's CEO, Rory Riggs, for the purchase and sale of 1,298,040 shares of its Class A Comm ...

BOSTON, June 10, 2024 (GLOBE NEWSWIRE) -- Block & Leviton is investigating Cibus, Inc. (Nasdaq: CBUS) for potential securities law violations. Investors who have lost money in their Cibus investment should contact the firm to learn more about how they might recover those losses. For more details, visit https://blockleviton.com/cases/cbus. What is this all about? Shares of Cibus fell significantly Tuesday morning after Bonitas Research issued a report alleging that they "found no evidence that Cibus' gene-ed ...

NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Cibus, Inc. (“Cibus” or the “Company”) (NASDAQ: CBUS) on behalf of Cibus stockholders. Our investigation concerns whether Cibus has violated the federal securities laws and/or engaged in other unlawful business practices. Click here to participate in the action. On June 4, 2024, Bonitas Research published a report alleging, among other things ...

NEW YORK, June 06, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Cibus, Inc. (“Cibus” or the “Company”) (NASDAQ: CBUS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Cibus and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices. [Click here for information about joining the class action] On June 4, 2024, Bonitas R ...